X. Chen-Zhao scite author profile

The prognosis for patients with high-grade glioma is poor despite aggressive multimodal treatment. About 90% of these lesions recur intracranially. The frequency of spinal cord disease is less than 2%. We report two cases of high-grade glioma with spinal drop metastases. One of the learning points we want to share is to think in the possibility of spinal cord metastases from brain gliomas. When symptoms are suggestive of spinal cord compromise, spine MRI should be done.

show abstract

Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre

Valero

Montero

Hernando

et al. 2021

Clin Transl Oncol

View full text Add to dashboard Cite

Low-dose radiation therapy for hand osteoarthritis: shaking hands again?

et al. 2021

View full text Add to dashboard Cite

PO-1233: Perioperative Radiotherapy with a Moderate Dose-Escalation for Retroperitoneal Sarcoma (RPS).

Baez¹,

Montero²,

Chen-Zhao³

et al. 2020

Radiotherapy and Oncology

View full text Add to dashboard Cite

PO-1134 MRI and PET response after preoperative radiochemotherapy in HER2+/triple negative breast cancer

Montero¹,

Ciérvide²,

Garcia-Aranda³

et al. 2021

Radiotherapy and Oncology

View full text Add to dashboard Cite

PO-1049 Hypofractionated stereotactic reirradiation in patients with high-grade gliomas

González¹,

Ciérvide²,

Hernando³

et al. 2021

Radiotherapy and Oncology

View full text Add to dashboard Cite

Comparison between RECIST 1.1, Choi and PERCIST 1.0 criteria to evaluate response to SBRT of liver metastasis

Krauel¹,

Chen-Zhao²,

Báez³

et al. 2021

AME Med J

View full text Add to dashboard Cite

12 3

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

X. Chen-Zhao

A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer

Diagnosis and management of spinal metastasis of primary brain tumours

Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre

Low-dose radiation therapy for hand osteoarthritis: shaking hands again?

PO-1233: Perioperative Radiotherapy with a Moderate Dose-Escalation for Retroperitoneal Sarcoma (RPS).

PO-1134 MRI and PET response after preoperative radiochemotherapy in HER2+/triple negative breast cancer

PO-1049 Hypofractionated stereotactic reirradiation in patients with high-grade gliomas

Comparison between RECIST 1.1, Choi and PERCIST 1.0 criteria to evaluate response to SBRT of liver metastasis

Contact Info

Product

Resources

About